Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. (Q39144950)
Jump to navigation
Jump to search
scientific article published on 28 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. |
scientific article published on 28 May 2013 |
Statements
Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model (English)
S Marconi
M Bonaconsa
I Scambi
G M Squintani
W Rui
E Turano
D Ungaro
S D'Agostino
F Barbieri
S Angiari
A Farinazzo
G Constantin
U Del Carro